Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
Healthcare
$6.64 +1.28%
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
52W Low $11.40High $16.77
Volume 0.22M
Average 0.35M
RNA Long-term Debt
Borrowings due after more than one year.
Atrium Therapeutics, Inc.NASDAQ: RNA
Long-term Debt · Q1 FY2026 · quarter ended Mar 2026
Long-term debt of $0 in Q1 FY2026
Q1 FY2026 long-term debt was $0.
Context
- Long-term debt amounted to 0.0% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Long-term Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Long-term Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Sign in to see up to ten periods of history.Sign in
Long-term Debt vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Long-term Debt figures are available to compare.
Balance Sheet
USD
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.